0001209191-20-055062.txt : 20201016
0001209191-20-055062.hdr.sgml : 20201016
20201016164914
ACCESSION NUMBER: 0001209191-20-055062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201014
FILED AS OF DATE: 20201016
DATE AS OF CHANGE: 20201016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novo Holdings A/S
CENTRAL INDEX KEY: 0001388325
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 201244448
BUSINESS ADDRESS:
STREET 1: TUBORG HAVNEVEJ 19
CITY: HELLERUP
STATE: G7
ZIP: 2900
BUSINESS PHONE: 45 8824 8824
MAIL ADDRESS:
STREET 1: TUBORG HAVNEVEJ 19
CITY: HELLERUP
STATE: G7
ZIP: 2900
FORMER NAME:
FORMER CONFORMED NAME: Novo A/S
DATE OF NAME CHANGE: 20070130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 294-1687
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-14
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001388325
Novo Holdings A/S
TUBORG HAVNEVEJ 19
HELLERUP
G7
2900
DENMARK
0
0
1
0
COMMON STOCK
2020-10-14
4
C
0
4739336
A
4739336
D
COMMON STOCK
2020-10-14
4
P
0
250000
15.00
A
4989336
D
SERIES A CONVERTIBLE PREFERRED STOCK
2020-10-14
4
C
0
21000000
D
COMMON STOCK
3210518
0
D
SERIES B CONVERTIBLE PREFERRED STOCK
2020-10-14
4
C
0
10000000
D
COMMON STOCK
1528818
0
D
The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted on a 6.541-to-1 basis into the number of shares of common stock as shown in Column 7 upon the completion of the Issuer's initial public offering without payment of further consideration. These shares have no expiration date.
Represents a purchase from the underwriters in the Issuer's initial public offering.
Novo Holdings A/S is a Danish limited liability company. The board of directors of Novo Holdings A/S (the "Novo Board") has shared investment and voting control over the securities of the Issuer held by Novo Holdings A/S (the "Shares") and may exercise such control only with the support of a majority of the Novo Board. As such, no individual member of the Novo Board is deemed to hold any beneficial ownership or reportable pecuniary interest in the Shares.
/s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S
2020-10-16